Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

ARCACHON PHARMA : revenue, balance sheet and financial ratios

ARCACHON PHARMA is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ARCACHON (33120), this company of category PME shows in 2016 a revenue of 473 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ARCACHON PHARMA (SIREN 794621805)
Indicator 2018 2016
Revenue N/C 472 543 €
Net income -81 850 € -38 153 €
EBITDA N/C -20 566 €
Net margin N/C -8.1%

Revenue and income statement

In 2018, ARCACHON PHARMA records a net loss of 82 k€. This deficit will reduce equity on the balance sheet.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-81 850 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 2650%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

2649.839%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

3.369%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

86.2%

Solvency indicators evolution
ARCACHON PHARMA

Sector positioning

Debt ratio
2649.84 2018
2016
2018
Q1: 40.91
Med: 114.65
Q3: 265.65
Watch

In 2018, the debt ratio of ARCACHON PHARMA (2649.84) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
3.37% 2018
2016
2018
Q1: 21.63%
Med: 38.4%
Q3: 58.06%
Watch

In 2018, the financial autonomy of ARCACHON PHARMA (3.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-13.27 years 2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Excellent

In 2016, the repayment capacity of ARCACHON PHARMA (-13.27) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 256.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

256.974

Liquidity indicators evolution
ARCACHON PHARMA

Sector positioning

Liquidity ratio
256.97 2018
2016
2018
Q1: 118.22
Med: 162.8
Q3: 228.3
Excellent +53 pts over 2 years

In 2018, the liquidity ratio of ARCACHON PHARMA (256.97) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-61.48x 2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.32x
Watch

In 2016, the interest coverage of ARCACHON PHARMA (-61.5x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
ARCACHON PHARMA

Positioning of ARCACHON PHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare ARCACHON PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about ARCACHON PHARMA

What is the revenue of ARCACHON PHARMA ?

The revenue of ARCACHON PHARMA in 2016 is 473 k€.

Is ARCACHON PHARMA profitable?

ARCACHON PHARMA recorded a net loss in 2018.

Where is the headquarters of ARCACHON PHARMA ?

The headquarters of ARCACHON PHARMA is located in ARCACHON (33120), in the department Gironde.

Where to find the tax return of ARCACHON PHARMA ?

The tax return of ARCACHON PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ARCACHON PHARMA operate?

ARCACHON PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.